EFFECTIVE TUMOR VACCINE GENERATED BY FUSION OF HEPATOMA-CELLS WITH ACTIVATED B-CELLS

被引:143
作者
GUO, YJ [1 ]
WU, MC [1 ]
CHEN, H [1 ]
WANG, XN [1 ]
LIU, GL [1 ]
LI, GL [1 ]
MA, J [1 ]
SY, MS [1 ]
机构
[1] CASE WESTERN RESERVE UNIV,INST PATHOL,CLEVELAND,OH 44106
关键词
D O I
10.1126/science.7507262
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Fusion of BERH-2 rat hepatocellular carcinoma cells with activated B cells produced hybrid cells that lost their tumorigenicity and became immunogenic. Syngeneic rats injected with BERH-2-B hybrid cells became resistant to challenge with parental BERH-2 cells, and rats with established BERH-2 hepatomas were cured by subsequent injection of BERH-2-B cells. Both CD4+ and CD8+ cells were essential for the induction of protective immunity; however, only CD8+ cells were required for the eradication of BERH-2 tumors. The generation of hybrid tumor cells that elicit antitumor immune responses may be a useful strategy for cancer immunotherapy.
引用
收藏
页码:518 / 520
页数:3
相关论文
共 18 条
[1]  
ALAN J, 1988, IMMUNOCHEMISTRY PRAC, pCH2
[2]   TUMOR SUPPRESSION AFTER TUMOR-CELL TARGETED TUMOR-NECROSIS-FACTOR-ALPHA GENE-TRANSFER [J].
BLANKENSTEIN, T ;
QIN, ZH ;
UBERLA, K ;
MULLER, W ;
ROSEN, H ;
VOLK, HD ;
DIAMANTSTEIN, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (05) :1047-1052
[3]   COSTIMULATION OF ANTITUMOR IMMUNITY BY THE B7 COUNTERRECEPTOR FOR THE LYMPHOCYTE-T MOLECULES CD28 AND CTLA-4 [J].
CHEN, LP ;
ASHE, S ;
BRADY, WA ;
HELLSTROM, I ;
HELLSTROM, KE ;
LEDBETTER, JA ;
MCGOWAN, P ;
LINSLEY, PS .
CELL, 1992, 71 (07) :1093-1102
[4]  
CHESTNUT RW, 1981, J IMMUNOL, V128, P1075
[5]  
ELIOT BE, 1989, ADV CANCER RES, V53, P181
[6]   INTERLEUKIN-2 PRODUCTION BY TUMOR-CELLS BYPASSES T-HELPER FUNCTION IN THE GENERATION OF AN ANTITUMOR RESPONSE [J].
FEARON, ER ;
PARDOLL, DM ;
ITAYA, T ;
GOLUMBEK, P ;
LEVITSKY, HI ;
SIMONS, JW ;
KARASUYAMA, H ;
VOGELSTEIN, B ;
FROST, P .
CELL, 1990, 60 (03) :397-403
[7]  
GEORGE JT, 1993, CANCER RES, V53, P2374
[8]  
Guo Y., UNPUB
[9]  
GUO YJ, 1988, J MIL MED COLL PEOPL, V3, P272